Nanoencapsulated and microencapsulated SERS platforms for biomedical analysis

Abstract

The problems of layer-by-layer-based surface enhancement Raman scattering (SERS)-sensor application for pharmaceutical analysis were discussed. Layer-by-layer (LbL) method allows fabrication of encapsulated SERS platforms with high reproducibility of enhancement factor and increased signal/noise ratio of Raman scattering. LbL encapsulation approach opens an avenue to implement a novel type of theranostic systems combining SERS based sensing and drug delivery in one entity. The area of encapsulation development toward smart multifunctional theranostic systems could bring benefits for personalized medicine and should minimize costs and resources at preclinical and clinical study in pharmacology while testing new bioactive compounds.

Original language	English
Pages (from-to)	149-158
Number of pages	10
Journal	Current Opinion in Pharmacology
Volume	18
DOIs	https://doi.org/10.1016/j.coph.2014.10.002
Publication status	Published - 2014
Externally published	Yes

ASJC Scopus subject areas

Drug Discovery
Pharmacology
Medicine(all)

Access to Document

10.1016/j.coph.2014.10.002

Fingerprint Dive into the research topics of 'Nanoencapsulated and microencapsulated SERS platforms for biomedical analysis'. Together they form a unique fingerprint.

Cite this

@article{30232d2140bd45589034fdc0c7aa6584,

title = "Nanoencapsulated and microencapsulated SERS platforms for biomedical analysis",

abstract = "The problems of layer-by-layer-based surface enhancement Raman scattering (SERS)-sensor application for pharmaceutical analysis were discussed. Layer-by-layer (LbL) method allows fabrication of encapsulated SERS platforms with high reproducibility of enhancement factor and increased signal/noise ratio of Raman scattering. LbL encapsulation approach opens an avenue to implement a novel type of theranostic systems combining SERS based sensing and drug delivery in one entity. The area of encapsulation development toward smart multifunctional theranostic systems could bring benefits for personalized medicine and should minimize costs and resources at preclinical and clinical study in pharmacology while testing new bioactive compounds.",

author = "Stetciura, {Inna Y.} and Markin, {Alexey V.} and Bratashov, {Daniil N.} and Sukhorukov, {Gleb B.} and Gorin, {Dmitry A.}",

year = "2014",

doi = "10.1016/j.coph.2014.10.002",

language = "English",

volume = "18",

pages = "149--158",

journal = "Current Opinion in Pharmacology",

issn = "1471-4892",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Nanoencapsulated and microencapsulated SERS platforms for biomedical analysis

AU - Stetciura, Inna Y.

AU - Markin, Alexey V.

AU - Bratashov, Daniil N.

AU - Sukhorukov, Gleb B.

AU - Gorin, Dmitry A.

PY - 2014

Y1 - 2014

N2 - The problems of layer-by-layer-based surface enhancement Raman scattering (SERS)-sensor application for pharmaceutical analysis were discussed. Layer-by-layer (LbL) method allows fabrication of encapsulated SERS platforms with high reproducibility of enhancement factor and increased signal/noise ratio of Raman scattering. LbL encapsulation approach opens an avenue to implement a novel type of theranostic systems combining SERS based sensing and drug delivery in one entity. The area of encapsulation development toward smart multifunctional theranostic systems could bring benefits for personalized medicine and should minimize costs and resources at preclinical and clinical study in pharmacology while testing new bioactive compounds.

AB - The problems of layer-by-layer-based surface enhancement Raman scattering (SERS)-sensor application for pharmaceutical analysis were discussed. Layer-by-layer (LbL) method allows fabrication of encapsulated SERS platforms with high reproducibility of enhancement factor and increased signal/noise ratio of Raman scattering. LbL encapsulation approach opens an avenue to implement a novel type of theranostic systems combining SERS based sensing and drug delivery in one entity. The area of encapsulation development toward smart multifunctional theranostic systems could bring benefits for personalized medicine and should minimize costs and resources at preclinical and clinical study in pharmacology while testing new bioactive compounds.

UR - http://www.scopus.com/inward/record.url?scp=84908173968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908173968&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2014.10.002

DO - 10.1016/j.coph.2014.10.002

M3 - Article

C2 - 25450069

AN - SCOPUS:84908173968

VL - 18

SP - 149

EP - 158

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

ER -